Characterization of childhood precursor T-lymphoblastic lymphoma by lmmunophenotyping and fluorescent in situ hybridization: A report from the Children's Oncology Group

Pediatric Blood and Cancer

Volumn 51, Issue 4, 2008, Pages 489-494

  Smock, Kristi J ^a   Nelson, Marilu ^b   Tripp, Sheryl R ^a   Sanger, Warren G ^b   Abromowitch, Minnie ^c   Cairo, Mitchell S ^d   Perkins, Sherrie L ^a  

^a ARUP LABORATORIES   (United States)

^b UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

^c Childrens Hospital of Omaha   (United States)

^d Och Spine at New York Presbyterian Hospitals   (United States)

Author keywords

Fluorescence in situ hybridization; Immunohistochemistry; Immunophenotyping; Molecular analysis; T cell lymphoblastic lymphoma

Indexed keywords

KI 67 ANTIGEN; MYC PROTEIN; ONCOPROTEIN; PARAFFIN; PROTEIN BCL 2; PROTEIN BCL 6; PROTEIN P53; PROTEIN TCL 1; S PHASE KINASE ASSOCIATED PROTEIN 2; T LYMPHOCYTE RECEPTOR ALPHA CHAIN; T LYMPHOCYTE RECEPTOR DELTA CHAIN; UNCLASSIFIED DRUG;

ACUTE LYMPHOBLASTIC LEUKEMIA; ARTICLE; CANCER PATIENT; CHILDHOOD CANCER; DIAGNOSTIC PROCEDURE; FLUORESCENCE IN SITU HYBRIDIZATION; GENE EXPRESSION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOPHENOTYPING; NONHODGKIN LYMPHOMA; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; T CELL LEUKEMIA; T LYMPHOBLASTIC LYMPHOMA;

CHILD; HUMANS; IMMUNOHISTOCHEMISTRY; IMMUNOPHENOTYPING; IN SITU HYBRIDIZATION, FLUORESCENCE; MEDICAL ONCOLOGY; PRECURSOR T-CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA;

EID: 50249170951     PISSN: 15455009     EISSN: 15455017     Source Type: Journal    
DOI: 10.1002/pbc.21666     Document Type: Article

References (22)

1. Reddy KS, Perkins SL. Advances in the diagnostic approach to childhood lymphoblastic malignant neoplasms. Am J Clin Pathol 2004;122:S3-S18.
2. Cairo M, Raetz E, Perkins S. Non-Hodgkin lymphoma in children, Cancer Medicine. London: BC Decker Inc; 2006.
3. Cairo MS, Raetz E, Lim MS, et al. Childhood and adolescent non-Hodgkin lymphoma: New insights in biology and critical challenges for the future. Pediatr Blood Cancer 2005;45:753-769.
4. Tubergen DG, Krailo MD, Meadows AT, et al. Comparison of treatment regimens for pediatric lymphoblastic non-Hodgkin's lymphoma: A Childrens Cancer Group study. J Clin Oncol 1995;13:1368-1376.
5. Abromowitch M, Sposto R, Perkins SL, et al. Results of CCG-5941 : Intensified multiagent chemotherapy and non-cross resistant maintenance therapy for advanced lymphoblastic lymphoma in children and adolescents. Presented, American Society of Hematology Annual Meeting, 2006. Blood 2006;108:#533.
6. Graux C, Cools J, Michaux L, et al. Cytogenetics and molecular genetics of T-cell acute lymphoblastic leukemia: From thymocyte to lymphoblast. Leukemia 2006;20:1496-1510.
7. Heerema NA, Sather HN, Sensel MG, et al. Frequency and clinical significance of cytogenetic abnormalities in pediatric T-lineage acute lymphoblastic leukemia: A report from the Children's Cancer Group. J Clin Oncol 1998;16:1270-1278.
8. Cauwelier B, Dastugue N, Cools J, et al. Molecular cytogenetic study of 126 unselected T-ALL cases reveals high incidence of TCRbeta locus rearrangements and putative new T-cell oncogenes. Leukemia 2006;20:1238-1244.
9. De Keersrnaecker K, Marynen P, Cools J. Genetic insights in the pathogenesis of T-cell acute lymphoblastic leukemia. Haematologica 2005;90:1116-1127.
10. Schneider NR, Carroll AJ, Shuster JJ, et al. New recurring cytogenetic abnormalities and association of blast cell karyotypes with prognosis in childhood T-cell acute lymphoblastic leukemia: A pediatric oncology group report of 343 cases. Blood 2000;96:2543-2549.
11. Lones MA, Heerema NA, Le Beau MM, et al. Chromosome abnormalities in advanced stage lymphoblastic lymphoma of children and adolescents: A report from CCG-E08. Cancer Genet Cytogenet 2007;172:1-11.
12. Raetz EA, Perkins SL, Bhojwani D, et al. Gene expression profiling reveals intrinsic differences between T-cell acute lymphoblastic leukemia and T-cell lymphoblastic lymphoma. Pediatr Blood Cancer 2006;47:130-140.
13. Armstrong SA, Look AT. Molecular genetics of acute lymphoblastic leukemia. J Clin Oncol 2005;23:6306-6315.
14. Sharma VM, Calvo JA, Draheim KM, et al. Notch1 contributes to mouse T-cell leukemia by directly inducing the expression of c-myc. Mol Cell Biol 2006;26:8022-8031.
15. Palomero T, Lim WK, Odom DT, et al. NOTCH1 directly regulates c-MYC and activates a feed-forward-loop transcriptional network promoting leukemic cell growth. Proc Natl Acad Sci USA 2006;103:18261-18266.
16. Weng AP, Millholland JM, Yashiro-Ohtani Y, et al. c-Myc is an important direct target of Notch1 in T-cell acute lymphoblastic leukemia/lymphoma. Genes Dev 2006;20:2096-2109.
17. Kawamura M, Ohnishi H, Guo SX, et al. Alterations of the p53, p21, p16, p15 and RAS genes in childhood T-cell acute lymphoblastic leukemia. Leuk Res 1999;23:115-126.
18. Naresh KN, Banavali SD, Bhatia KG, et al. Expression of P53 and bcl-2 proteins in T-cell lymphoblastic lymphoma: Prognostic implications. Leuk Lymphoma 2002;43:333-337.
19. Villuendas R, Piris MA, Algara P, et al. The expression of p53 protein in non-Hodgkin's lymphomas is not always dependent on p53 gene mutations. Blood 1993;82:3151-3156.
20. Hyjek E, Chadburn A, Liu YF, et al. BCL-6 protein is expressed in precursor T-cell lymphoblastic lymphoma and in prenatal and postnatal thymus. Blood 2001;97:270-276.
21. Teitell MA. The TCL1 family of oncoproteins: Co-activators of transformation. Nat Rev Cancer 2005;5:640-648.
22. Kossatz U, Dietrich N, Zender L, et al. Skp2-dependent degradation of p27kip1 is essential for cell cycle progression. Genes Dev 2004;18:2602-2607.